7 patents
Utility
Pharmaceutical Composition Comprising a Potent Inhibitor of URAT1
12 Jan 23
The present invention relates to pharmaceutical compositions containing 2-((3-(4-cyanonaphthalen-1-yl)pyridine-4-yl)thio)-2-methylpropanoic acid or a pharmaceutically acceptable salt (hereinafter referred to as the “Agent”), more particularly to orally deliverable compositions containing the Agent; to the use of said compositions as a medicament; and to processes for the preparation of said compositions.
Joanne REILAND WAKEMAN, Colin ROWLINGS, Sha LIU, Gerry BURKE, Christian VON CORSWANT, Christer TANNERGREN, Johan HJÄRTSTAM
Filed: 23 Jun 22
Utility
Thioacetate Compounds, Compositions and Methods of Use
10 Jun 21
Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them.
Samedy OUK, Esmir GUNIC, Jean-Michel VERNIER, Chixu CHEN
Filed: 16 Dec 20
Utility
Pharmaceutical Composition Comprising a Potent Inhibitor of URAT1
22 Apr 21
The present invention relates to pharmaceutical compositions containing 2-((3-(4-cyanonapthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid or a pharmaceutically acceptable salt (hereinafter referred to as the “Agent”), more particularly to orally deliverable compositions containing the Agent; to the use of said compositions as a medicament; and to processes for the preparation of said compositions.
Joanne REILAND WAKEMAN, Colin ROWLINGS, Sha LIU, Gerry BURKE, Christian VON CORSWANT, Christer TANNERGREN, Johan HJÄRTSTAM
Filed: 31 Aug 20
Utility
Thioacetate compounds, compositions and methods of use
16 Feb 21
Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them.
Samedy Ouk, Esmir Gunic, Jean-Michel Vernier, Chixu Chen
Filed: 14 Nov 18
Utility
CXCR-2 inhibitors for treating crystal arthropathy disorders
14 Sep 20
Payal Nanavati, Jeffrey Miner
Filed: 8 Mar 17
Utility
CXCR-2 Inhibitors for Treating Disorders
9 Sep 20
Payal NANAVATI, Johan HOEGSTEDT, Jesse HALL
Filed: 13 Oct 19
Utility
3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
24 Feb 20
2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid is useful in the modulation of blood or serum uric acid levels.
Li-Tain Yeh, Barry D. Quart
Filed: 8 Jul 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first